Chronic Kidney Disease Interplay with Comorbidities and Carbohydrate Metabolism: A Review

被引:0
|
作者
Kushwaha, Radha [1 ]
Vardhan, Pothabathula Seshu [2 ]
Kushwaha, Prem Prakash [3 ]
Georgianos, Panagiotis
机构
[1] Univ Allahabad, Ctr Food Technol, Allahabad 211002, Uttar Pradesh, India
[2] Sardar Vallabhbhai Natl Inst Technol SVNIT, Dept Chem, Surat 395007, Gujarat, India
[3] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA
来源
LIFE-BASEL | 2024年 / 14卷 / 01期
关键词
chronic kidney disease; cellular growth homeostasis; inflammation; insulin resistance; dietary interventions; CHRONIC-RENAL-FAILURE; CLINICAL-PRACTICE GUIDELINES; BLOOD-PRESSURE VARIABILITY; OXIDATIVE STRESS; GROWTH-HORMONE; COGNITIVE IMPAIRMENT; ALL-CAUSE; CARDIOVASCULAR MORTALITY; INTERNATIONAL SOCIETY; HEMODIALYSIS-PATIENTS;
D O I
10.3390/life14010013
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chronic kidney disease (CKD) poses a global health challenge, engendering various physiological and metabolic shifts that significantly impact health and escalate the susceptibility to severe illnesses. This comprehensive review delves into the intricate complexities of CKD, scrutinizing its influence on cellular growth homeostasis, hormonal equilibrium, wasting, malnutrition, and its interconnectedness with inflammation, oxidative stress, and cardiovascular diseases. Exploring the genetic, birth-related, and comorbidity factors associated with CKD, alongside considerations of metabolic disturbances, anemia, and malnutrition, the review elucidates how CKD orchestrates cellular growth control. A pivotal focus lies on the nexus between CKD and insulin resistance, where debates persist regarding its chronological relationship with impaired kidney function. The prevalence of insulin abnormalities in CKD is emphasized, contributing to glucose intolerance and raising questions about its role as a precursor or consequence. Moreover, the review sheds light on disruptions in the growth hormone and insulin-like growth factor axis in CKD, underscoring the heightened vulnerability to illness and mortality in cases of severe growth retardation. Wasting, a prevalent concern affecting up to 75% of end-stage renal disease (ESRD) patients, is analyzed, elucidating the manifestations of cachexia and its impact on appetite, energy expenditure, and protein reserves. Taste disturbances in CKD, affecting sour, umami, and salty tastes, are explored for their implications on food palatability and nutritional status. Independent of age and gender, these taste alterations have the potential to sway dietary choices, further complicating the management of CKD. The intricate interplay between CKD, inflammation, oxidative stress, and cardiovascular diseases is unraveled, emphasizing the profound repercussions on overall health. Additionally, the review extends its analysis to CKD's broader impact on cognitive function, emotional well-being, taste perception, and endothelial dysfunction. Concluding with an emphasis on dietary interventions as crucial components in CKD management, this comprehensive review navigates the multifaceted dimensions of CKD, providing a nuanced understanding essential for developing targeted therapeutic strategies.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities
    Rodelo-Haad, Cristian
    Pendon-Ruiz de Mier, M. Victoria
    Diaz-Tocados, Juan Miguel
    Martin-Malo, Alejandro
    Santamaria, Rafael
    Munoz-Castaneda, Juan Rafael
    Rodriguez, Mariano
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [22] Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)
    Ali, Mariam M.
    Parveen, Sanober
    Williams, Vanessa
    Dons, Robert
    Uwaifo, Gabriel I.
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2024, 36
  • [23] The bone-vessel interplay in pediatric chronic kidney disease
    Preka, E.
    Ranchin, B.
    Boutroy, S.
    Doyon, A.
    Cochat, P.
    Bacchetta, J.
    [J]. PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1916 - 1917
  • [24] SARCOIDOSIS, HYPERCALCEMIA AND THEIR INTERPLAY WITH SECONDARY HYPERPARATHYROIDISM IN CHRONIC KIDNEY DISEASE
    Ahmad, Masood
    Jain, Gaurav
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 540 - 540
  • [25] Iron Metabolism in Chronic Kidney Disease Patients
    Honda, Hirokazu
    Hosaka, Nozomu
    Ganz, Tomas
    Shibata, Takanori
    [J]. CKD-ASSOCIATED COMPLICATIONS: PROGRESS IN THE LAST HALF CENTURY, 2019, 198 : 103 - 111
  • [26] HDL metabolism and activity in chronic kidney disease
    Nosratola D. Vaziri
    Mohamad Navab
    Alan M. Fogelman
    [J]. Nature Reviews Nephrology, 2010, 6 : 287 - 296
  • [27] Disorder of iron metabolism in chronic kidney disease
    Nanami, Masayoshi
    Nagasawa, Yasuyuki
    Hasuike, Yukiko
    Kuragano, Takahiro
    Nakanishi, Takeshi
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 49P - 49P
  • [28] Disorders of Lipid Metabolism in Chronic Kidney Disease
    Bulbul, Mustafa C.
    Dagel, Tuncay
    Afsar, Baris
    Ulusu, Nuray N.
    Kuwabara, Masanarini
    Covic, Adrian
    Kanbay, Mehmet
    [J]. BLOOD PURIFICATION, 2018, 46 (02) : 144 - 152
  • [29] Bone metabolism in chronic kidney disease in childhood
    Haffner, D.
    Querfeld, U.
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2013, 161 (11) : 1011 - +
  • [30] Biomarkers of iron metabolism in chronic kidney disease
    Tomasz, Glogowski
    Ewa, Wojtaszek
    Jolanta, Malyszko
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (05) : 935 - 944